About Vivacta
Vivacta is a company based in Sittingbourne (United Kingdom) founded in 1991 was acquired by Novartis in December 2012. It operates as a B2B. Vivacta has raised $30.22 million across 5 funding rounds from investors including Novartis, Idinvest Partners and HBM Healthcare Investments. Vivacta operates in a competitive market with competitors including Imperative Care, Bardy Diagnostics, EarlySense, LUMA Vision and Bloomer Tech, among others.
- Headquarter Sittingbourne, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vivacta
Vivacta has successfully raised a total of $30.22M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.4 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vivacta
Vivacta has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Idinvest Partners and HBM Healthcare Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage tech and energy investments in Europe are targeted.
|
Locked | Locked | Locked | |
|
Equity investments are provided to low and middle market companies.
|
Locked | Locked | Locked | |
|
Early-stage tech and life science investments are made in Europe.
|
Locked | Locked | Locked |
Investor details for Vivacta
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vivacta
Investment portfolio details for Vivacta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vivacta
Detailed financials for Vivacta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivacta Comparisons
Peer comparison for Vivacta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vivacta
Vivacta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imperative Care, Bardy Diagnostics, EarlySense, LUMA Vision and Bloomer Tech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Access catheters for neurovascular stroke treatment are provided.
|
|
| Locked | Locked | Locked |
Develops and markets the Carnation Ambulatory Monitor
|
|
| Locked | Locked | Locked |
Develops innovative smart devices for cardiac health monitoring.
|
|
| Locked | Locked | Locked |
Developer of interventional cardiac imaging devices
|
|
| Locked | Locked | Locked |
Smart innerwear with embedded sensors for cardiac monitoring is provided.
|
|
| Locked | Locked | Locked |
Targeted metabolic phenotyping kits are developed for research and diagnostics.
|
Detailed competitors of Vivacta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivacta
Complete news archive for Vivacta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivacta
Vivacta was founded in 1991 and raised its 1st funding round 15 years after it was founded.
Vivacta is headquartered in Sittingbourne, United Kingdom.
Vivacta is a funded company, having raised a total of $30.22M across 5 funding rounds to date.
Vivacta, founded in 1991 in Sittingbourne, United Kingdom, focuses on providing healthcare solutions, developing medical devices, diagnostic tools, and point-of-care testing. Provides a versatile platform for point-of-care testing solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Vivacta's top competitors include Imperative Care, LUMA Vision and Biocrates.
Vivacta has 7 investors. Key investors include Novartis, Idinvest Partners, HBM Healthcare Investments, Viking Technology, and Viking Venture.